Validation of Bevacizumab Therapy Effect on Colon Cancer Subtypes by Using Whole Body Imaging in Mice.

MLA

Vuletic, Ivan, et al. “Validation of Bevacizumab Therapy Effect on Colon Cancer Subtypes by Using Whole Body Imaging in Mice.” Molecular Imaging and Biology, vol. 19, no. 6, Dec. 2017, pp. 847–56. EBSCOhost, https://doi.org/10.1007/s11307-017-1048-z.

APA

Vuletic, I., Zhou, K., Li, H., Bai, H., Meng, X., Zhu, S., Ding, Y., Li, J., Sun, H., & Ren, Q. (2017). Validation of Bevacizumab Therapy Effect on Colon Cancer Subtypes by Using Whole Body Imaging in Mice. Molecular Imaging and Biology, 19(6), 847–856. https://doi.org/10.1007/s11307-017-1048-z

Chicago

Vuletic, Ivan, Kedi Zhou, Hui Li, Huichen Bai, Xiangxi Meng, Sihao Zhu, Yichen Ding, Jun Li, Hongfang Sun, and Qiushi Ren. 2017. “Validation of Bevacizumab Therapy Effect on Colon Cancer Subtypes by Using Whole Body Imaging in Mice.” Molecular Imaging and Biology 19 (6): 847–56. doi:10.1007/s11307-017-1048-z.